Aripiprazole cavoxil

Aripiprazole, marketed as Abilify &#174 , is an atypical antipsychotic and antidepressant drug used to treat schizophrenia, bipolar disorder, and clinical depression. This new internal standard is suitable for the quantitation of aripiprazole in

This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including forensic or clinical toxicology analysis and urine drug testing. Dehydro Aripiprazole is the primary, active metabolite of aripiprazole, marketed as

Dehydro Aripiprazole is the primary, active metabolite of aripiprazole, marketed as the atypical antipsychotic Abilify &#174 for the treatment of schizophrenia, bipolar disorder, and clinical depression. This new certified solution standard is